ArticleNeurosurgical review2006
Local elevation of the anti-inflammatory interleukin-10 in the pathogenesis of chronic subdural hematoma.
Article in Neurosurgical review, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 46 citations in OpenAlex.
- A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial).Health technology assessment (Winchester, England) · 2024Trial
- Effect of ATorvastatin On Chronic subdural Hematoma (ATOCH): a study protocol for a randomized controlled trial.Trials · 2015Trial
- Chronic subdural hematoma through the hallmarks of aging: a geroscience framework for the commonest neurosurgical condition of older adults.GeroScience · 2026Review
- The pathophysiology of chronic subdural hematoma revisited: emphasis on aging processes as key factor.GeroScience · 2022Review
- Impact of inflammatory cell ratio, biomarkers, activated partial thromboplastin time and prothrombin time on chronic subdural haematoma severity and outcome.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2022Article
- Serum Levels of MMP-8 and MMP-9 as Markers in Chronic Subdural Hematoma.Journal of clinical medicine · 2022Article
- Dexamethasone reduces vascular endothelial growth factor in comparison to placebo in post-operative chronic subdural hematoma samples: A target for future drug therapy?Frontiers in neurology · 2022Article
- Immunoexpression of MMP-8 and MMP-9 in chronic subdural hematoma.Frontiers in neurology · 2022Article
- Article
- Dex-CSDH randomised, placebo-controlled trial of dexamethasone for chronic subdural haematoma: report of the internal pilot phase.Scientific reports · 2019Article
- Article
- Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy.Journal of neuroinflammation · 2017Review
- Statins in conditions other than hypocholesterolemic effects for chronic subdural hematoma therapy, old drug, new tricks?Oncotarget · 2017Review
- Association between biomarkers and clinical characteristics in chronic subdural hematoma patients assessed with lasso regression.PloS one · 2017Article
- Local and systemic pro-inflammatory and anti-inflammatory cytokine patterns in patients with chronic subdural hematoma: a prospective study.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2012Article
- Chronic subdural hematoma.Asian journal of neurosurgeryReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We investigated the relationship between inflammatory and anti-inflammatory cytokines in the pathogenesis of chronic subdural hematoma (CSDH) by measuring the plasma and subdural fluid levels of interleukin-6 (IL-6), interleukin-8 (IL-8), and interleukin-10 (IL-10). The levels of IL-6, IL-8 and IL-10 were measured in the subdural fluid obtained from 34 patients with CSDH, using the enzyme-linked immunosorbent assay. The patients were classified into a high IL-10 group and a low IL-10 group according to the level of IL-10 in their subdural fluid samples. The subdural fluid levels of IL-6 and IL-8 were significantly higher in the high IL-10 group than in the low IL-10 group (P<0.05). A tendency for the patients in the low IL-10 group to show the separated or layer type of pattern on the CT scans was noted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.